Photopharmics
Manufacturing · Utah, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3451 N Triumph Blvd Ste 201, Lehi, Utah,...Phone Number
(801) 770-6960Website
www.photopharmics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Photopharmics
PhotoPharmics is a pioneer in specialized phototherapy aimed at treating neurodegenerative diseases, particularly Parkinson's disease. Their personalized at-home device, Celeste specialized phototherapy, addresses both motor and non-motor symptoms, showing promising results in clinical studies. The company targets individuals living with Parkinson's, offering a new therapeutic approach that enhances quality of life without major side effects. Future plans include expanding their innovative solutions to Alzheimer's and other neurodegenerative conditions.Explore more
Photopharmics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Photopharmics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Photopharmics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Photopharmics recently announced quarterly report
Product Launch: Get notified when Photopharmics launches new products
Check if Photopharmics has recently received funding, and reach out quickly before it becomes old news!
Photopharmics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Photopharmics
Click to see if Photopharmics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Photopharmics has new funding data
Recommended Actions
Reach out to Masked Content who joined Photopharmics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Photopharmics
Compare insights from companies similar to Photopharmics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Photopharmics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Photopharmics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Photopharmics.
Photopharmics financials insights
Gather financial insights about Photopharmics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$2.1M
2017
Private Equity
$2.3M
Debt
$2.6M
2023
Other Financing Round
$18M
2025
Other Financing Round
$6M
Photopharmics Tech Stack
A closer look at the technologies used by Photopharmics
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Person-Based
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Photopharmics
Sign Up For FreeTo access detailed company insights
PhotoPharmics is a pioneer in specialized phototherapy aimed at treating neurodegenerative diseases, particularly Parkinson's disease. Their personalized at-home device, Celeste specialized phototherapy, addresses both motor and non-motor symptoms, showing promising results in clinical studies. The company targets individuals living with Parkinson'... Read More
